Regulating the isotypic and idiotypic profile of an anti-PC antibody response: Lessons from peptide mimics

Molecular Immunology

Volumn 39, Issue 5-6, 2002, Pages 263-272

  Harris, Shannon L ^a   Dagtas, Ayse Selma ^a   Diamond, Betty ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antigenic mimics; Peptides; Phage display; Phosphorylcholine; Streptococcus pneumoniae

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; PEPTIDE DERIVATIVE; PHOSPHORYLCHOLINE; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE LIBRARY; PHOSPHORYLCHOLINE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036772506     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00116-5     Document Type: Article

References (41)

1. Briles D.E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:1981;694-705.
2. Briles D.E., Forman C., Hudak S., Claflin J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1982;1177-1185.
3. Briles D.E., Forman C., Hudak S., Claflin J.L. The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur. J. Immunol. 14:1984a;1027-1030.
4. Briles D.E., Forman C., Hudak S., Claflin J.L. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J. Mol. Cell Immunol. 1:1984;305-309.
5. Brown M., Wiens G.D., O'Hare T., Stenzel-Poore M.P., Rittenberg M.B. Replacements in the exposed loop of the T15 antibody VH CDR2 affect carrier recognition of PC-containing pathogens. Mol. Immunol. 36:1999;205-211.
6. Casadevall A., DeShaw M., Fan M., Dromer F., Kozel T.R., Pirofski L.A. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:1994;3864-3872.
7. Chu R.S., McCool T., Greenspan N.S., Schreiber J.R., Harding C.V. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect. Immun. 68:2000;1450-1456.
8. De Bolle X., Laurent T., Tibor A., Godfroid F., Weynants V., Letesson J.J., Mertens P. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella. J. Mol. Biol. 294:1999;181-191.
9. Der Balian G.P., Slack J., Clevinger B.L., Bazin H., Davie J.M. Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J. Exp. Med. 152:1980;209-218.
10. Desaymard C., Giusti A.M., Scharff M.D. Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol. Immunol. 21:1984;961-967.
11. Fleuridor R., Lees A., Pirofski L. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J. Immunol. 166:2001;1087-1096.
12. Granoff D.M., Bartoloni A., Ricci S., Gallo E., Rosa D., Ravenscroft N., Guarnieri V., Seid R.C., Shan A., Usinger W.R., Tan S., McHugh Y.E., Moe G.R. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160:1998;5028-5036.
13. Grothaus M.C., Srivastava N., Smithson S.L., Kieber-Emmons T., Williams D.B., Carlone G.M., Westerink M.A. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine. 18:2000;1253-1263.
14. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:2000;31-36.
15. Haas, S.J., Smith, G.P., 1993. Rapid sequencing of viral DNA from filamentous bacteriophage. Biotechniques 15, 422-424, 426-428, 431.
16. Harris S.L., Craig L., Mehroke J.S., Rashed M., Zwick M.B., Kenar K., Toone E.J., Greenspan N., Auzanneau F.I., Marino-Albernas J.R., Pinto B.M., Scott J.K. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2454-2459.
17. Harris S.L., Park M.K., Nahm M.H., Diamond B. Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae. Infect. Immun. 68:2000;5778-5784.
18. Hoess R., Brinkmann U., Handel T., Pastan I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene. 128:1993;43-49.
19. Kang C.Y., Brunck T.K., Kieber-Emmons T., Blalock J.E., Kohler H. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science. 240:1988;1034-1036.
20. Kenny J.J., Moratz C.M., Guelde G., O'Connell C.D., George J., Dell C., Penner S.J., Weber J.S., Berry J., Claflin J.L. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine- specific antibodies: a model for T15-idiotype dominance. J. Exp. Med. 176:1992;1637-1643.
21. Lee W., Cosenza H., Kohler H. Clonal restriction of the immune response to phosphorylcholine. Nature. 247:1974;55-57.
22. Limpanasithikul W., Ray S., Diamond B. Cross-reactive antibodies have both protective and pathogenic potential. J. Immunol. 155:1995;967-973.
23. Moe G.R., Tan S., Granoff D.M. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol. Med. Microbiol. 26:1999;209-226.
24. Mukherjee J., Kozel T.R., Casadevall A. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. J. Immunol. 161:1998;3557-3568.
25. Nicoletti C. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen. Exp. Mol. Pathol. 62:1995;99-108.
26. Nussbaum G., Yuan R., Casadevall A., Scharff M.D. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J. Exp. Med. 183:1996;1905-1909.
27. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:2000;302-317.
28. Perlmutter R.M., Hansburg D., Briles D.E., Nicolotti R.A., Davie J.M. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:1978;566-572.
29. Phalipon A., Folgori A., Arondel J., Sgaramella G., Fortugno P., Cortese R., Sansonetti P.J., Felici F. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur. J. Immunol. 27:1997;2620-2625.
30. Pincus S.H., Smith M.J., Jennings H.J., Burritt J.B., Glee P.M. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J. Immunol. 160:1998;293-298.
31. Segal D.M., Padlan E.A., Cohen G.H., Rudikoff S., Potter M., Davies D.R. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. U.S.A. 71:1974;4298-4302.
32. Smith G.P., Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257.
33. Spira G., Aguila H.L., Scharff M.D. T15 PC-binding monoclonal antibodies retain specificity when they switch from IgM to IgG. J. Immunol. 140:1988;2675-2680.
34. Stein K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165(Suppl. 1):1992;S49-S52.
35. Valadon P., Nussbaum G., Boyd L.F., Margulies D.H., Scharff M.D. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:1996;11-22.
36. Valadon P., Nussbaum G., Oh J., Scharff M.D. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J. Immunol. 161:1998;1829-1836.
37. Westerink M.A., Giardina P.C., Apicella M.A., Kieber-Emmons T. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4021-4025.
38. Wiens G.D., Roberts V.A., Whitcomb E.A., O'Hare T., Stenzel-Poore M.P., Rittenberg M.B. Harmful somatic mutations: lessons from the dark side. Immunol. Rev. 162:1998;197-209.
39. Yuan R., Casadevall A., Spira G., Scharff M.D. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1995;1810-1816.
40. Yuan R., Clynes R., Oh J., Ravetch J.V., Scharff M.D. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J. Exp. Med. 187:1998a;641-648.
41. Yuan R.R., Spira G., Oh J., Paizi M., Casadevall A., Scharff M.D. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect. Immun. 66:1998;1057-1062.